At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
Multimodal Neuromonitoringother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients
In Brief
An observational study evaluating Multimodal Neuromonitoring for Intracerebral Hemorrhage and 4 related conditions. Completed, enrolled 65 participants across 1 site.
Detailed Summary
The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIntracerebral Hemorrhage, Critically Ill, Intracranial Pressure, Cerebral Perfusion Pressure, Prognostic
CountriesPortugal
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedAug 2022
Primary CompletionOct 2022
Study CompletionFeb 2023
TodayJul 2026
First PostedAug 15, 2022
Enrollment StartJan 1, 2015
Primary CompletionOct 1, 2022
Study CompletionFeb 1, 2023
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 3.9 years ago
Interventions
Multimodal Neuromonitoringother
Invasive Multimodal Neuromonitoring